Serum cholesterol and cognitive functions: The Lothian Birth Cohort 1936

International Psychogeriatrics

Volumn 27, Issue 3, 2015, Pages 439-453

  Corley, Janie ^a   Starr, John M ^a,b   Deary, Ian J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

aging; childhood IQ; cholesterol; cognitive function

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; COGNITION; COHORT ANALYSIS; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEMORY; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; VERBAL BEHAVIOR; AGING; BLOOD; CROSS-SECTIONAL STUDY; INTELLIGENCE; INTELLIGENCE TEST; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SCOTLAND; SOCIAL CLASS;

AGED; AGING; CHILD; CHOLESTEROL, HDL; COGNITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; SCOTLAND; SOCIAL CLASS; TRIGLYCERIDES;

EID: 84922247391     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214001197     Document Type: Article

References (95)

1. Abbott, R. D. et al. (1997). Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Annals of Epidemiology, 7, 417-424.
2. Adult Treatment Panel III (2001). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Journal of the American Medical Association, 285, 2486-2497.
3. Anstey, K., Lipnicki, D. and Low, L. (2008). Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. American Journal of Geriatric Psychiatry, 16, 343-354. doi:10.1097/JGP.0b013e31816b72d4.
4. Atzmon, G. et al. (2002). Plasma HDL levels highly correlate with cognitive function in exceptional longevity. Journal of Gerontology. Series A, Biological Sciences and Medical Sciences, 57, M712-M715. doi:10.1093/gerona/57.11.M712.
5. Batty, G. D. and Deary, I. J. (2004). Early life intelligence and adult health. British Medical Journal, 329, 585-586. doi:10.1136/bmj.329.7466.585.
6. Batty, G. D., Deary, I. J., Schoon, I. and Gale, C. R. (2007). Childhood mental ability in relation to food intake and physical activity in adulthood: the 1970 British Cohort Study. Pediatrics, 119, e38-e45. doi:10.1542/peds.2006-1831.
7. Benito-León, J., Louis, E. D., Vega, S. and Bermejo-Pareja, F. (2010). Statins and cognitive functioning in the elderly: a population-based study. Journal of Alzheimer's Disease, 21, 95-102. doi:10.3233/JAD-2010-100180.
8. Bernick, C. et al.; Cardiovascular Health Study Collaborative Research Group (2005). Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology, 65, 1388-1394. doi:10.1212/01.wnl.0000182897.18229.ec.
9. Berry, J. D. et al. (2008). Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. American Journal of Cardiology, 101, 89-94. http://dx.doi.org/10.1016/j.amjcard.2007.07.079.
10. Beydoun, M. A. et al. (2010). Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. Journal of Epidemiology and Community Health, 65, 949-957. doi:10.1136/jech.2009.100826.
11. Brescianini, S. et al.; ILSA Group (2003). Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. Journal of the American Geriatrics Society, 51, 991-996. doi:10.1046/j.1365-2389.2003.51313.x.
12. Brownell, K. D., Bachorik, P. S. and Averle, R. S. (1982). Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise. Circulation, 65, 477-484.
13. Calvin, C. et al. (2011). Intelligence in youth and all-cause-mortality: systematic review with meta-analysis. International Journal of Epidemiology, 40, 626-644. doi:10.1093/ije/dyq190.
14. Carlsson, C. M. et al. (2008). Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. Journal of Alzheimer's Disease, 13, 187-197.
15. Cook, Z. (2005). Diet will help reduce cholesterol levels. Professional Nursing, 20, 44.
16. Corley, J., Gow, A. J., Starr, J. M. and Deary, I. J. (2010). Is body mass index in old age related to cognitive abilities? The Lothian Birth Cohort 1936 Study. Psychology and Aging, 25, 867-875. doi:10.1037/a0020301.
17. Coscina, D. V., Yehuda, S., Dixon, L. M, Kish, S. J. and Leprohon-Greenwood, C. E. (1986). Learning is improved by a soybean oil diet in rats. Life Sciences, 38, 1789-1794. http://dx.doi.org/10.1016/0024-3205(86)90130-X.
18. Cox, B. D., Huppert, F. A. and Whichelow, M. J. (1993). The Health and Lifestyle Survey: Seven Years On. Aldershot, UK: Dartmouth.
19. de Freitas, E. V. et al. (2011). Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly. Archives of Gerontology and Geriatrics, 52, 217-222. doi:10.1016/j.archger.2010.03.022.
20. Deary, I. J., Der, G. and Ford, G. (2001). Reaction times and intelligence differences: a population-based cohort study. Intelligence, 29, 389-399. doi:10.1016/S0160-2896(01)00062-9.
21. Deary, I. J., Weiss, A. and Batty, G. D. (2010). Intelligence and personality as predictors of illness and death: how researchers in differential psychology and chronic disease epidemiology are collaborating to understand and address health inequalities. Psychological Science in the Public Interest, 11, 53-79. doi:10.1177/1529100610387081.
22. Deary, I. J., Whalley, L. J., Lemmon, H., Crawford, J. R. and Starr, J. M. (2000). The stability of individual differences in mental ability from childhood to old age: follow up of the 1932 Scottish Mental Survey. Intelligence, 28, 49-55. doi:10.1016/S0160-2896(99)00031-8.
23. Deary, I. J., Whalley, L. J. and Starr, J. M. (2009). A Lifetime of Intelligence: Follow-up Studies of the Scottish Mental Surveys of 1932 and 1947. Washington, DC: American Psychological Association.
24. Deary, I. J. et al. (2004). The functional anatomy of inspection time: an event-related fMRI study. NeuroImage, 22, 1466-1479. doi:10.1016/j.neuroimage.2004.03.047.
25. Deary, I. J. et al. (2007). The Lothian Birth Cohort 1936: a study to examine the influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatrics, 7, 28. doi:10.1186/1471-2318-7-28.
26. Delgado-Rodríguez, M. et al. (2002). Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. Archives of Surgery, 137, 805-812. doi:10.1001/archsurg.137.7.805.
27. Dyker, A. G., Weir, C. J. and Lees, K. R. (1997). Influence of cholesterol on survival after stroke: retrospective study. British Medical Journal, 314, 1584-1588. doi:http://dx.doi.org/10.1136/bmj.314.7094.1584.
28. Elias, P. K., Elias, M. F., D'Agostino, R. B., Sullivan, L. M. and Wolf, P. A. (2005). Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosomatic Medicine, 67, 24-30. doi:10.1097/01.psy.0000151745.67285.c2.
29. Ellison, R. C. et al. (2004). Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Investigators of the NHLBI Family Heart Study. American Heart Journal, 147, 529-35. doi:10.1016/j.ahj.2003. 10.033.
30. Folsom, A. R. et al. (1994). Body mass, fat distribution and cardiovascular risk factors in a lean population of south China. Journal of Clinical Epidemiology, 47, 173-181. doi.org/10.1016/0895-4356(94)90022-1.
31. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
32. Formiga, F. et al. (2011). Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenarians. Geriatrics and Gerontology International, 11, 358-364. doi:10.1111/j.1447-0594.2010.00681.x.
33. Formiga, F. et al. (2012). Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects. Journal of Nutrition, Health and Aging, 16, 449-453. doi:10.1007/s12603-012-0018-z.
34. Gaziano, J. (2012). Should we fast before we measure our lipids? Archives of Internal Medicine, 172, 1705-1706. doi:10.1001/jamainternmed.2013.1771.
35. Gottfredson, L. S. (2004). Intelligence: is it the epidemiologists' elusive "fundamental cause" of social class inequalities in health? Journal of Personality and Social Psychology, 86, 174-199. doi:10.1037/0022-3514.86.1.174.
36. Hagger-Johnson, G., Mõttus, R., Craig, L. C., Starr, J. M. and Deary, I. J. (2012). Pathways from childhood intelligence and socioeconomic status to late-life cardiovascular disease risk. Health Psychology, 4, 403-412. doi:10.1037/a0026775.
37. Henderson, V.W., Guthrie, J. R. and Dennerstein, L. (2003). Serum lipids and memory in a population based cohort of middle age women. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1530-1535. doi:10.1136/jnnp.74.11.1530.
38. Hertzog, C., Kramer, A. F., Wilson, R. S. and Lindenberger, U. (2009). Enrichment effects on adult cognitive development: can the functional capacity of older adults be preserved and enhanced? Psychological Science in the Public Interest, 9, 1-65. doi:10.1111/j.1539-6053.2009.01034.x.
39. Ingelsson, E. et al. (2007). Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Journal of the American Medical Association, 298, 776-785. doi:10.1001/jama.298.7.776.
40. Jia, X., Craig, L. C., Aucott, L. S., Milne, A. C. and McNeill, G. (2008). Repeatability and validity of a food frequency questionnaire in free-living older people in relation to cognitive function. Journal of Nutrition Health and Aging, 12, 735-741. doi: 10.1007/BF03028622.
41. Karlamangla, A. S., Singer, B. H., Reuben, D. B. and Seeman, T. E. (2004). Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging. Journal of the American Geriatrics Society, 52, 487-494. doi:10.1111/j.1532-5415.2004.52152.x.
42. Kilgour, A. H. M., Starr, J. M. and Whalley, L. J. (2010). Associations between childhood intelligence (IQ), adult morbidity and mortality. Maturitas, 65, 98-105. doi.org/10.1016/j.maturitas.2009.09.021.Kilgour.
43. Kivipelto, M. and Solomon, A. (2006). Cholesterol as a risk factor for Alzheimer's Disease-epidemiological evidence. Acta psychiatrica et neurologica Scandinavica Supplementum, 185, 50-57. doi:10.1111/j.1600-0404.2006.00685.x.
44. Langsted, A., Freiberg, J. J. and Nordestgaard, B. G. (2008). Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation, 118, 2047-2056. doi:10.1161/CIRCULATIONAHA.108.804146.
45. Law, M. R., Wald, N. J. and Thompson, S. G. (1994). By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? British Medical Journal, 308, 367-372.
46. Lee, Y. et al. (2010). Systematic review of health behavioral risks and cognitive health in older adults. International Psychogeriatrics, 22, 174-187. doi:10.1017/S1041610209991189.
47. Li, G. et al. (2005). Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology, 65, 1045-1050. doi:10.1212/01.wnl.0000178989.87072.11.
48. Luciano, M. et al. (2009). Cognitive ability at age 11 and 70 years, information processing speed, and APOE variation: the Lothian Birth Cohort 1936 Study. Psychology and Aging, 24, 129-138. doi:10.1037/a0014780.
49. McNeill, G., Winter, J. and Jia, X. (2009). Diet and cognitive function in later life: a challenge for nutritional epidemiology. European Journal of Clinical Nutrition, 63, S33-S37. doi:10.1038/ejcn.2011.2.
50. Mielke, M. M. et al. (2005). High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology, 64, 1689-1695. doi:10.1212/01.WNL.0000161870.78572.A5.
51. Mielke, M. M. et al. (2008). Baseline serum cholesterol is selectively associated with motor speed and not rates of cognitive decline: the Women's Health and Aging Study II. Journal of Gerontology. Series A, Biological Sciences and Medical Sciences, 63, 619-624.
52. Muldoon, M. F., Ryan, C. M., Matthews, K. A. and Manuck, S. B. (1997). Serum cholesterol and intellectual performance. Psychosomatic Medicine, 59, 382-387.
53. Nelson, H. E. and Willison, J. R. (1991). National Adult Reading Test (NART) Test Manual (Part II). Windsor, UK: NFER-Nelson.
54. Office of Population Censuses and Surveys. ( 1980). Classification of Occupations 1980. London, UK: Her Majesty's Stationery Office.
55. Onder, G. et al. (2003). Serum cholesterol levels and in-hospital mortality in the elderly. American Journal of Medicine, 115, 265-271. http://dx.doi.org/10.1016/S0002-9343(03)00354-1.
56. Panza, F. et al. (2009). Higher total cholesterol, cognitive decline, and dementia. Neurobiology of Aging, 30, 546-548. doi:10.1016/j.neurobiolaging.2007.10.019.
57. Parale, G. P., Baheti, N. N., Kulkarni, P. M. and Panchal, N. V. (2006) Effects of atorvastatin on higher functions. European Journal of Clinical Pharmacology, 62, 259-265. doi:10.1007/s00228-005-0073-z.
58. Piguet, O. et al. (2003). Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology, 22, 165-171. doi:10.1159/000069886.
59. Prospective Studies Collaboration (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet, 370, 1829-1839. http://dx.doi.org/10.1016/S0140-6736(07)61778-4.
60. Reitz, C., Luchsinger, J., Tang, M. X., Manly, J. and Mayeux, R. (2005). Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology, 64, 1378-1383. doi:10.1212/01.WNL.0000158274.31318.3C.
61. Reitz, C., et al. (2008). Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 25, 232-237. doi:10.1159/000115847.
62. Reitz, C. et al. (2010). Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Archives of Neurology, 67, 1491-1497. doi:10.1001/archneurol.2010.297.
63. Reynolds, C. A., Gatz, M., Prince, J. A., Berg, S. and Pedersen, N. L. (2010). Serum lipid levels and cognitive change in late life. Journal of the American Geriatrics Society, 58, 501-509. doi:10.1111/j.1532-5415.2010.02739.x.
64. Rockwood, K. et al. (2002). Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Archives of Neurology, 59, 223-227. doi:10.1001/archneur.59.2.223.
65. Sacker, A., Schoon, I. and Bartley, M. (2002). Social inequality in educational achievement and psychosocial adjustment throughout childhood: magnitude and mechanisms. Social Science and Medicine, 55, 863-880. http://dx.doi.org/10.1016/S0277-9536(01)00228-3.
66. Sacks, F. (1994). Dietary fats and coronary heart disease. Overview. Journal of Cardiovascular Risk, 1, 3-8.
67. Schalk, B. W., Visser, M., Deeg, D. J. and Bouter, L. M. (2004). Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age and Ageing, 33, 266-272. doi:10.1093/ageing/afh073.
68. Schatz, I. J. et al. (2001). Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet, 358, 351-355. http://dx.doi.org/10.1016/S0140-6736(01)05553-2.
69. Schubert, C. M. et al. (2006). Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. International Journal of Obesity, 30, 251-260. doi:10.1038/sj.ijo.0803129.
70. Scottish Council for Research in Education. (1933). The Intelligence of Scottish Children: A National Survey of an Age Group. London, UK: University of London Press.
71. Scottish Council for Research in Education. (1949). The Trend of Scottish Intelligence: A Comparison of the 1947 and 1932 Surveys of the Intelligence of Eleven-year-old Pupils. London, UK: University of London Press.
72. Shepherd, J. et al.; PROSPER Study Group (2002). Prospective study of pravastatin in the elderly at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360, 1623-1630. doi.org/10.1016/S0021-9150(00)80775-3.
73. Simons, L. A., Simons, J., Friedlander, Y. and McCallum, J. (2001). Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis, 159, 201-208. doi.org/10.1016/S0021-9150(01)00495-6.
74. Siri-Tarino, P. W., Sun, Q., Hu, F. B. and Krauss, R. M. (2010) Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Current Atherosclerosis Reports, 12, 384-390. doi:10.1007/s11883-010-0131-6.
75. Solomon, A. et al. (2007). Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology, 68, 751-756. doi:10.1212/01.wnl.0000256368.57375.b7.
76. Solomon, A. et al. (2009) Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiology of Aging, 30, 1006-1009. doi.org/10.1016/j.neurobiolaging.2007.09.012.
77. Starr, J. M. et al. (2004). Life long changes in cognitive ability are associated with prescribed medications in old age. International Journal of Geriatric Psychiatry, 19, 327-332. doi:10.1002/gps.1093.
78. Thorsson, B. et al. (2013). Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic population. European Heart Journal, 34, 1778-1782. doi:10.1093/eurheartj/ehs395.
79. Tilvis, R. S., Valvanne, J. N., Strandberg, T. E. and Miettinen, T. A. (2011). Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age: a 17-year population study. Annals of Medicine, 43, 292-301. doi:10.3109/07853890.2010.546363.
80. Trompet, S. et al. (2010). Pravastatin and cognitive function in the elderly. Results of the PROSPER study. Journal of Neurology, 257, 85-90. doi:10.1007/s00415-009-5271-7.
81. van den Kommer, et al. (2009). Total cholesterol and oxysterols: early markers for cognitive decline in the elderly? Neurobiology of Aging, 30, 534-545. doi:10.1016/j.neurobiolaging.2007.08.005.
82. van Exel, E. et al. (2002). Association between high-density lipoprotein and cognitive impairment in the oldest old. Annals of Neurology, 51, 716-721. doi:10.1002/ana.10220.
83. van Vliet, P. (2012). Cholesterol and late-life cognitive decline. Journal of Alzheimer's Disease, 30 (Suppl. 2), S147-S162. doi:10.3233/JAD-2011-111028.
84. van Vliet, P., van de Water, W., de Craen, A. J. and Westendorp, R. G. (2009). The influence of age on the association between cholesterol and cognitive function. Experimental Gerontology, 44, 112-122. doi:10.1016/j.exger.2008.05.004.
85. Wechsler, D. (1998a). WAIS-IIIUK Administration and Scoring Manual. London, UK: Psychological Corporation.
86. Wechsler, D. (1998b). WMS-IIIUK Administration and Scoring Manual. London, UK: Psychological Corporation.
87. Weverling-Rijnsburger, A. W. et al. (1997). Total cholesterol and risk of mortality in the oldest old. Lancet, 350, 1119-1123. http://dx.doi.org/10.1016/S0140-6736(97)04430-9.
88. Whalley, L. J. and Deary, I. J. (2001). Longitudinal cohort study of childhood IQ and survival up to age 76. British Medical Journal, 322, 819. http://dx.doi.org/10.1136/bmj.322.7290.819.
89. Whalley, L. J., Fox, H. C., Whale, K. W., Starr, J. M. and Deary, I. J. (2004). Cognitive aging, childhood intelligence and the use of food supplements: possible involvement of n-3 fatty acids. American Journal of Clinical Nutrition, 80, 1650-1657.
90. Whalley, L. J. et al. (2003). Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. Neuroscience Letters, 341, 173-176. http://dx.doi.org/10.1016/S0304-3940(02)01452-0.
91. Whitehead, T. P., Robinson, D. and Allaway, S. L. (1996). The effects of cigarette smoking and alcohol consumption on blood lipids: a dose related study on men. Annals of Clinical Biochemistry, 33, 99-106.
92. Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C. and Yaffe, K. (2005). Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 64, 277-281. doi:10.1212/01.WNL.0000149519.47454.F2.
93. Willett, W. C. (2012). Dietary fats and coronary heart disease. Review. Journal of Internal Medicine, 272, 13-24.
94. Xiong, G. L., Benson, A. and Doraiswamy, P. M. (2005). Statins and cognition: what can we learn from existing randomized trials? CNS Spectrums, 10, 867-874.
95. Yaffe, K., Barrett-Connor, E., Lin, F. and Grady, D. (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Archives of Neurology, 59, 378-384. doi:10.1001/archneur.59.3.378.